Aller au contenu principal

Découvrez nos professeurs et professeures!

Emmanuel Planel

Professeur titulaire

Emmanuel Planel
Centre thématique de recherche en neurosciences
Centre de recherche du CHU de Québec - Université Laval
Partager la fiche :

Contribution à la recherche

Thématiques de recherche de la Faculté de médecine

  • Neurosciences et santé mentale

Projets de recherche en cours

  • Physiological regulation of tau protein - Conseil de recherches en sciences naturelles et génie Canada - Subventions à la découverte SD (individuelles et d'équipe), chercheur principal - 2023-04-01 au 2028-03-31
  • Microglial tau: a missing link between neuroinflammation and neurodegeneration in TDP-43 proteinopathies - Instituts de recherche en santé du Canada - Subvention Projet, co-chercheur - 2023-04-01 au 2028-03-31
  • Microglial tau: a missing link between neuroinflammation and neurodegeneration in TDP-43 proteinopathies - Instituts de recherche en santé du Canada - Subvention Projet, co-chercheur - 2023-03-01 au 2028-03-31

Financements des 2 dernières années

  • Mechanisms of neuronal and vascular impairments in ischemic retinopathies - Instituts de recherche en santé du Canada - Subvention Projet, chercheur principal - 2019-04-01 au 2024-03-31
  • Untangling tau contribution to cognitive impairments in Huntington’s disease. - Instituts de recherche en santé du Canada - Subvention Projet, co-chercheur - 2019-04-01 au 2024-03-31

Publications

  • Hypothermia and Alzheimer's disease neuropathogenic pathways., Planel E, Chouinard F, Papon MA, Whittington RA, Current Alzheimer research, 2010, 10.2174/156720510793611646
  • Differential Regulation of Tau Exon 2 and 10 Isoforms in Huntington's Disease Brain., St-Amour I, Hébert SS, Planel E, Sergeant N, Keraudren R, Nateghi B, Petry S, Neuroscience, 2022, 10.1016/j.neuroscience.2022.07.014
  • Differential effects of voluntary treadmill exercise and caloric restriction on tau pathogenesis in a mouse model of Alzheimer's disease-like tau pathology fed with Western diet., Planel E, Marette A, Morin F, Julien J, Gratuze M, Progress in neuro-psychopharmacology & biological psychiatry, 2017, 10.1016/j.pnpbp.2017.08.001
  • Sauna-like conditions or menthol treatment reduce tau phosphorylation through mild hyperthermia., Planel E, Hébert SS, Frédéric Calon, Whittington RA, Kérauden R, Françoise Morin, Fereydouni-Forouzandeh P, Pétry S, Geoffrey CANET, Isabelle GUISLE, Neurobiology of aging, 2022, 10.1016/j.neurobiolaging.2022.02.011
  • Untangling memory deficits., Planel E, Duff K, Nature medicine, 2005, 10.1038/nm0805-826
  • Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing., Duff K, Lahiri DK, Lau LF, Planel E, Liu L, Krishnamurthy P, Herman M, Figueroa H, Wang L, Maurin T, Marié I, Ma J, Bailey J, Maloney B, Yu WH, Wen Y, Neuron, 2008, 10.1016/j.neuron.2008.02.024
  • Is Huntington's disease a tauopathy?, Planel E, Cicchetti F, Cisbani G, Gratuze M, Brain : a journal of neurology, 2016, 10.1093/brain/aww021
  • Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia., Duff KE, Lau LF, Nelson RB, Schachter JB, Wang L, Herman M, Krishnamurthy P, Wen Y, Liu L, Finley JE, Nolan CE, Richter KE, Planel E, The Journal of neuroscience : the official journal of the Society for Neuroscience, 2007, 10.1523/jneurosci.4854-06.2007
  • Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease., Planel E, Whittington RA, Bissonnette S, Poitras I, Bezeau F, Goupil C, Dickler M, Morin F, Milot-Rousseau P, Cisbani G, Julien C, Noël A, Gratuze M, Human molecular genetics, 2014, 10.1093/hmg/ddu456
  • Hypothermia mediates age-dependent increase of tau phosphorylation in db/db mice., Planel E, Marette A, Hébert SS, Calon F, Nicholls SB, Morin F, Marcouiller F, Papon MA, Julien C, Petry F, Gratuze M, El Khoury NB, Neurobiology of disease, 2016, 10.1016/j.nbd.2016.01.005
  • Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Abeta accumulation., Small SA, Arancio O, Duff K, Ganetzky B, Honig LS, Kreber R, Ho L, Herman M, Planel E, Staniszewski A, Yu R, Zhang H, Flores I, Muhammad A, Proceedings of the National Academy of Sciences of the United States of America, 2008, 10.1073/pnas.0802545105
  • Seizure activity triggers tau hyperphosphorylation and amyloidogenic pathways., Nicola Marchi, Laurent Givalois, Planel E, Desrumaux C, Audinat E, Moreno-Montano M, deBock F, Vitalis M, Garcia V, Blaquiere M, Hernandez C, Zussy C, Zub E, Geoffrey CANET, Epilepsia, 2022, 10.1111/epi.17186
  • Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors., Planel E, Hébert SS, Lévesque G, Mouginot D, Poitras I, Petry FR, El Khoury NB, Julien C, Marcouiller F, Bretteville A, Scientific reports, 2012, 10.1038/srep00480
  • U-box protein carboxyl terminus of Hsc70-interacting protein (CHIP) mediates poly-ubiquitylation preferentially on four-repeat Tau and is involved in neurodegeneration of tauopathy., Takashima A, Nakayama KI, Takahashi R, Planel E, Chui DH, Murayama M, Kamura T, Matsumoto M, Hatakeyama S, Journal of neurochemistry, 2004, 10.1111/j.1471-4159.2004.02713.x
  • Corrigendum: Human Tau Expression Does Not Induce Mouse Retina Neurodegeneration, Suggesting Differential Toxicity of Tau in Brain vs. Retinal Neurons., Pernet V, Planel E, Boudreau-Laprise M, Joly S, Mdzomba JB, Rodriguez L, Frontiers in molecular neuroscience, 2018, 10.3389/fnmol.2018.00390
  • MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy., Hébert SS, Buée L, Sergeant N, Planel E, Papon MA, Girard J, Delay C, Smith PY, Human molecular genetics, 2011, 10.1093/hmg/ddr330
  • In vivo turnover of tau and APP metabolites in the brains of wild-type and Tg2576 mice: greater stability of sAPP in the beta-amyloid depositing mice., Mathews PM, Planel E, Matsuoka Y, Choi JH, Levy E, Diaz NS, Berger JD, Mazzella MJ, Morales-Corraliza J, PloS one, 2009, 10.1371/journal.pone.0007134
  • Repurposing beta-3 adrenergic receptor agonists for Alzheimer's disease: beneficial effects in a mouse model., Calon F, Pifferi F, Planel E, Mélançon K, Tremblay C, Hozer C, Vrabic N, Vu TM, Tournissac M, Alzheimer's research & therapy, 2021, 10.1186/s13195-021-00842-3
  • Impaired Resolution of Inflammation in Alzheimer's Disease: A Review., Terrando N, Planel E, Whittington RA, Frontiers in immunology, 2017, 10.3389/fimmu.2017.01464
  • ERK (MAPK) does not phosphorylate tau under physiological conditions in vivo or in vitro., Charron J, Planel E, Morin F, Petry FR, Julien J, Poitras I, Noël A, Neurobiology of aging, 2014, 10.1016/j.neurobiolaging.2014.11.005
  • Anesthesia and tau pathology., Planel E, Dickler MF, Bretteville A, Whittington RA, Progress in neuro-psychopharmacology & biological psychiatry, 2013, 10.1016/j.pnpbp.2013.03.004
  • Metabolic determinants of Alzheimer's disease: A focus on thermoregulation., Calon F, Planel E, Bosoi CR, Vandal M, Valentin-Escalera J, Leclerc M, Tournissac M, Ageing research reviews, 2021, 10.1016/j.arr.2021.101462
  • Regulation of brain insulin signaling: A new function for tau., Planel E, Gratuze M, The Journal of experimental medicine, 2017, 10.1084/jem.20170979
  • Anesthesia, surgery and neurodegeneration. Preface., Planel E, Eckenhoff RG, Progress in neuro-psychopharmacology & biological psychiatry, 2013, 10.1016/j.pnpbp.2013.10.012
  • Insulin dysfunction and Tau pathology., Planel E, Bretteville A, Papon MA, Gratuze M, El Khoury NB, Frontiers in cellular neuroscience, 2014, 10.3389/fncel.2014.00022
  • A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment., Duff K, Arancio O, Yu WH, Figueroa H, Herman M, Wang L, Krishnamurthy P, Bretteville A, Wen Y, Planel E, Orozco IJ, Liu L, Neurobiology of disease, 2008, 10.1016/j.nbd.2008.03.005
  • c-jun N-terminal kinase hyperphosphorylates R406W tau at the PHF-1 site during mitosis., Takashima A, Rivka R, Yoshioka K, Kikuchi N, Murayama M, Sahara N, Miyasaka T, Sato S, Chui DH, Planel E, Tatebayashi Y, FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2006, 10.1096/fj.05-4362fje
  • Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse., Ishiguro K, Fujita SC, Yasutake K, Planel E, The Journal of biological chemistry, 2001, 10.1074/jbc.m102780200
  • Biochemical isolation of insoluble tau in transgenic mouse models of tauopathies., Planel E, Bretteville A, Julien C, Methods in molecular biology (Clifton, N.J.), 2012, 10.1007/978-1-61779-551-0_32
  • A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease., Aisen PS, Gozes I, Arancio O, Planel E, Walker BR, Lecanu L, Feng L, Li HF, Hirata-Fukae C, Ma L, Gray AJ, Jouroukhin Y, Matsuoka Y, The Journal of pharmacology and experimental therapeutics, 2008, 10.1124/jpet.107.130526
  • Insulin resistance and obesity: how do they affect tau pathology?, Planel E, Morin F, Marcouiller F, Julien C, Papon M, DicklerI M, El Khoury N, Gratuze M, Molecular neurodegeneration, 2013, 10.1186/1750-1326-8-s1-p67
  • Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease., Cicchetti F, Freeman TB, Planel E, Kordower JH, Maxan A, Cisbani G, Brain : a journal of neurology, 2017, 10.1093/brain/awx255
  • Specificity of anti-tau antibodies when analyzing mice models of Alzheimer's disease: problems and solutions., Planel E, Whittington RA, Hébert SS, Calon F, Morin F, Bretteville A, Pelletier J, Petry FR, PloS one, 2014, 10.1371/journal.pone.0094251
  • Alzheimer's disease and anesthesia., Planel E, El-Khoury NB, Whittington RA, Papon MA, Frontiers in neuroscience, 2011, 10.3389/fnins.2010.00272
  • Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau., Takashima A, Hashikawa T, Sato S, Planel E, Ishiguro K, Murayama M, Tanemura K, Fujiwara M, Iwasaki K, Mishima K, Akagi T, Chui DH, Miyasaka T, Tatebayashi Y, Proceedings of the National Academy of Sciences of the United States of America, 2002, 10.1073/pnas.202205599
  • Insulin reverses the high-fat diet-induced increase in brain Aβ and improves memory in an animal model of Alzheimer disease., Calon F, Marette A, Giguere Y, Planel E, Virgili J, Lefrançois D, Emond V, Chevrier G, St-Amour I, Tremblay C, White PJ, Vandal M, Diabetes, 2014, 10.2337/db14-0375
  • Starvation and inhibition of lysosomal function increased tau secretion by primary cortical neurons., Leclerc N, Planel E, Rémillard-Labrosse G, Plouffe V, Mohamed NV, Scientific reports, 2014, 10.1038/srep05715
  • Dendritic Spine Loss and Chronic White Matter Inflammation in a Mouse Model of Highly Repetitive Head Trauma., Burns MP, Planel E, Villapol S, Zapple DN, Alikhani AD, Wilkins TE, Chellappa D, Barton DJ, Parsadanian M, Neustadtl A, Noël A, Winston CN, The American journal of pathology, 2016, 10.1016/j.ajpath.2015.11.006
  • Propofol directly increases tau phosphorylation., Planel E, Emala CW, Morin F, Julien C, El Khoury NB, Papon MA, Marcouiller F, Virág L, Whittington RA, PloS one, 2011, 10.1371/journal.pone.0016648
  • Anesthesia-induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivo., Duff KE, Nixon RA, Takashima A, Davies P, Whittington RA, Yu WH, Figueroa HY, Bretteville A, Kumar A, Herman M, Liu L, Miyasaka T, Krishnamurthy P, Planel E, The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008, 10.1523/jneurosci.4101-08.2008
  • Intranasal Administration of Nanovectorized Docosahexaenoic Acid (DHA) Improves Cognitive Function in Two Complementary Mouse Models of Alzheimer's Disease., Desrumaux C, Devarajan PV, Laurent Givalois, Rajshree SL, Durand T, OGER Camille, Planel E, Morin F, Vitalis M, Geoffrey CANET, Acar N, Claire VIGOR, Otaegui L, Urgin T, John R, Zussy C, Antioxidants (Basel, Switzerland), 2022, 10.3390/antiox11050838
  • Aberrant tau phosphorylation by glycogen synthase kinase-3beta and JNK3 induces oligomeric tau fibrils in COS-7 cells., Takashima A, Ishiguro K, Yoshioka K, Hashikawa T, Sun X, Tanemura K, Planel E, Miyasaka T, Murayama M, Chui DH, Akagi T, Tatebayashi Y, Sato S, The Journal of biological chemistry, 2002, 10.1074/jbc.m202241200
  • Postoperative cognitive decline: where art tau?, Planel E, Eckenhoff RG, Anesthesiology, 2012, 10.1097/aln.0b013e31824be8e1
  • Circadian and sleep/wake-dependent variations in tau phosphorylation are driven by temperature., Planel E, Mongrain V, Hébert SS, Whittington RA, Keraudren R, Petry S, Morin F, Gratuze M, Guisle I, Sleep, 2020, 10.1093/sleep/zsz266
  • Deregulation of protein phosphatase 2A and hyperphosphorylation of τ protein following onset of diabetes in NOD mice., Planel E, Hébert SS, Mathews PM, Amrani A, Gaudreau S, Petry FR, Bretteville A, Morin F, Julien C, Marcouiller F, El Khoury NB, Papon MA, Diabetes, 2012, 10.2337/db12-0187
  • Old age potentiates cold-induced tau phosphorylation: linking thermoregulatory deficit with Alzheimer's disease., Calon F, Planel E, François A, Vandal M, Tournissac M, Neurobiology of aging, 2016, 10.1016/j.neurobiolaging.2016.09.024
  • Arterial Stiffness Due to Carotid Calcification Disrupts Cerebral Blood Flow Regulation and Leads to Cognitive Deficits., Girouard H, Ferland G, Planel E, Petry FR, Gratuze M, Youwakim J, Vallerand D, Iulita MF, Muhire G, Journal of the American Heart Association, 2019, 10.1161/jaha.118.011630
  • Dimethyl sulfoxide induces both direct and indirect tau hyperphosphorylation., Planel E, Hébert SS, Baillargeon J, El Khoury NB, Bretteville A, Marcouiller F, Julien C, PloS one, 2012, 10.1371/journal.pone.0040020
  • Gene network and pathway analysis of mice with conditional ablation of Dicer in post-mitotic neurons., Hébert SS, Buée L, Zommer N, Planel E, Calvo E, Delay C, Smith PY, Dorval V, PloS one, 2012, 10.1371/journal.pone.0044060
  • A Simple Method to Avoid Nonspecific Signal When Using Monoclonal Anti-Tau Antibodies in Western Blotting of Mouse Brain Proteins., Planel E, Hébert SS, Nicholls SB, Petry FR, Methods in molecular biology (Clifton, N.J.), 2017, 10.1007/978-1-4939-6598-4_15
  • Tau aggregates: toxic, inert, or protective species?, Planel E, Bretteville A, Journal of Alzheimer's disease : JAD, 2008, 10.3233/jad-2008-14411
  • Human Tau Expression Does Not Induce Mouse Retina Neurodegeneration, Suggesting Differential Toxicity of Tau in Brain vs. Retinal Neurons., Planel E, Pernet V, Boudreau-Laprise M, Joly S, Mdzomba JB, Rodriguez L, Frontiers in molecular neuroscience, 2018, 10.3389/fnmol.2018.00293
  • Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing., Duff KE, Lau LF, Yu WH, Liu L, Wang L, Figueroa HY, Planel E, Herman M, Wen Y, The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008, 10.1523/jneurosci.5245-07.2008
  • Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia., Duff KE, Whittington RA, Dickson DW, Yu WH, Du AL, Virag L, Liu L, Bretteville A, Planel E, FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2009, 10.1096/fj.08-122424
  • Co-occurrence of mixed proteinopathies in late-stage Huntington's disease., Hébert SS, Planel E, Goupil C, Turgeon A, St-Amour I, Acta neuropathologica, 2017, 10.1007/s00401-017-1786-7
  • Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease., Takashima A, Tatebayashi Y, Ishiguro K, Murayama O, Sato S, Tanemura K, Chui DH, Launey T, Miyasaka T, Planel E, The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004, 10.1523/jneurosci.5561-03.2004
  • Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer's disease-like tau pathology., Planel E, Morin F, Petry FR, Julien J, Gratuze M, Scientific reports, 2017, 10.1038/srep46359
  • The toxin MPTP generates similar cognitive and locomotor deficits in hTau and tau knock-out mice., Planel E, Bretzner F, Cicchetti F, Samadi P, Morin F, Bezeau F, Julien J, Poitras I, Truchetti G, Eyoum Jong L, Pflieger M, Petry FR, Josset N, Gratuze M, Brain research, 2019, 10.1016/j.brainres.2019.01.016
  • Anesthesia-induced hypothermia mediates decreased ARC gene and protein expression through ERK/MAPK inactivation., Planel E, Charron J, Morin F, El-Khoury NB, Petry FR, Julien C, Marcouiller F, Maurin TO, Emala CW, Virág L, Bretteville A, Whittington RA, Scientific reports, 2013, 10.1038/srep01388
  • miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo., Hébert SS, Fernandez-Gomez FJ, Bennett DA, Planel E, Morin F, Parsi S, Dorval V, Goupil C, Bisht K, Lecours C, Jolivette F, Hernandez-Rapp J, Smith PY, Human molecular genetics, 2015, 10.1093/hmg/ddv377
  • Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo., Duff K, Bhat R, Wen Y, Krishnamurthy P, Burns M, Feinstein B, LaFrancois J, Wang L, Suleman F, Gaynor K, Meyerson J, Olm V, Zehr C, Planel E, Noble W, Proceedings of the National Academy of Sciences of the United States of America, 2005, 10.1073/pnas.0500466102
  • Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration., De Strooper B, Buée L, Sergeant N, Silahtaroglu AN, Planel E, Galas MC, Smith P, Papadopoulou AS, Hébert SS, Human molecular genetics, 2010, 10.1093/hmg/ddq311
  • Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt (3xTg-AD)., Planel E, Calon F, Julien C, Theriault P, Lalonde R, Filali M, Behavioural brain research, 2012, 10.1016/j.bbr.2012.07.004
  • Impaired thermoregulation and beneficial effects of thermoneutrality in the 3×Tg-AD model of Alzheimer's disease., Calon F, Marette A, Planel E, Traversy MT, Bousquet M, Drouin-Ouellet J, St-Amour I, Tremblay C, Tournissac M, White PJ, Vandal M, Neurobiology of aging, 2016, 10.1016/j.neurobiolaging.2016.03.024
  • Anaesthetic neurotoxicity and neuroplasticity: an expert group report and statement based on the BJA Salzburg Seminar., Hemmings HC, Planel E, Ma D, Orser BA, Loepke AW, Herold KF, Giffard RG, Fiskum G, Culley DJ, Crosby G, Brambrink A, Blomgren K, Absalom AR, Jevtovic-Todorovic V, British journal of anaesthesia, 2013, 10.1093/bja/aet177
  • Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms., Takashima A, Duff KE, Wadzinski B, Luchsinger JA, Yu WH, Herman M, Wang L, Liu L, Miyasaka T, Tatebayashi Y, Planel E, The Journal of neuroscience : the official journal of the Society for Neuroscience, 2007, 10.1523/jneurosci.3949-07.2007
  • Consensus statement: First International Workshop on Anesthetics and Alzheimer's disease., First International Workshop on Anesthetics and Alzheimer's Disease, Planel E, Perouansky M, Palotás A, Jevtovic-Todorovic V, Hogan KJ, Eckenhoff RG, Eckenhoff MF, Culley DJ, Crosby GJ, Bickler PE, Baranov D, Anesthesia and analgesia, 2009, 10.1213/ane.0b013e318199dc72
  • Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein., Duff KE, Clark LN, Cookson MR, Planel E, Wang L, Figueroa HY, Dorado B, Yu WH, The American journal of pathology, 2009, 10.2353/ajpath.2009.080928
  • Age-dependent impairment of glucose tolerance in the 3xTg-AD mouse model of Alzheimer's disease., Calon F, Marette A, Planel E, St-Amour I, Tremblay C, Chevrier G, White PJ, Vandal M, FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2015, 10.1096/fj.14-268482
  • Passive immunization against phosphorylated tau improves features of Huntington's disease pathology., Francesca Cicchetti, Planel E, Davies P, Saint-Pierre M, Denis HL, Eva LEPINAY, Aurelie de Rus Jacquet, Masnata M, Melanie Alpaugh, Molecular therapy : the journal of the American Society of Gene Therapy, 2022, 10.1016/j.ymthe.2022.01.020
  • High-fat, high-sugar, and high-cholesterol consumption does not impact tau pathogenesis in a mouse model of Alzheimer's disease-like tau pathology., Planel E, Marette A, Hébert SS, Calon F, Morin F, Julien J, Gratuze M, Neurobiology of aging, 2016, 10.1016/j.neurobiolaging.2016.07.016
  • Administration of the benzodiazepine midazolam increases tau phosphorylation in the mouse brain., Planel E, Morin F, Poitras I, Petry F, Cheheltanan M, Lewkowitz-Shpuntoff H, Gratuze M, Virág L, Whittington RA, Neurobiology of aging, 2018, 10.1016/j.neurobiolaging.2018.10.027
  • Repeated cold exposures protect a mouse model of Alzheimer's disease against cold-induced tau phosphorylation., Calon F, Planel E, Hébert SS, Vu TM, Martinez-Cano RD, Bourassa P, Tournissac M, Molecular metabolism, 2019, 10.1016/j.molmet.2019.01.008
  • microRNA-132/212 deficiency enhances Aβ production and senile plaque deposition in Alzheimer's disease triple transgenic mice., Hébert SS, Cicchetti F, Calon F, Droit A, Planel E, Vallée M, Saint-Pierre M, Smith PY, Dorval V, Goupil C, Rainone S, Hernandez-Rapp J, Scientific reports, 2016, 10.1038/srep30953
  • Tau hyperphosphorylation in the brain of ob/ob mice is due to hypothermia: Importance of thermoregulation in linking diabetes and Alzheimer's disease., Planel E, Calon F, Marette A, Whittington RA, Morin F, Marcouiller F, Julien C, Turgeon A, El Khoury NB, Gratuze M, Neurobiology of disease, 2016, 10.1016/j.nbd.2016.10.004
  • Starvation induces tau hyperphosphorylation in mouse brain: implications for Alzheimer's disease., Fujita SC, Ishiguro K, Planel E, Yanagisawa M, FEBS letters, 1999, 10.1016/s0014-5793(99)01480-5
  • Dexmedetomidine increases tau phosphorylation under normothermic conditions in vivo and in vitro., Morin F, Planel E, Bretteville A, Wong K, El Khoury N, Papon MA, Marcouiller F, Truchetti G, Poitras I, Noël A, Petry FR, Gratuze M, Virág L, Whittington RA, Neurobiology of aging, 2015, 10.1016/j.neurobiolaging.2015.05.002
  • Advances and Challenges in Understanding MicroRNA Function in Tauopathies: A Case Study of miR-132/212., Hébert SS, Planel E, St-Amour I, Turgeon A, Goupil C, Loiselle A, Rainone S, Keraudren R, Petry S, Hernandez-Rapp J, Boscher E, Frontiers in neurology, 2020, 10.3389/fneur.2020.578720
  • Memory formation and retention are affected in adult miR-132/212 knockout mice., Hébert SS, Goodman RH, Magill ST, Planel E, Goupil C, Filali M, Smith PY, Hernandez-Rapp J, Behavioural brain research, 2015, 10.1016/j.bbr.2015.03.032
  • Repurposing beta3-adrenergic receptor agonists for Alzheimer’s disease: Beneficial effects on recognition memory and amyloid pathology in a mouse model, Calon F, Pifferi F, Planel E, Mélançon K, Tremblay C, Hozer C, Vu T, Vrabic N, Tournissac M, 2020, 10.1101/2020.05.25.114454
  • MicroRNA-138 Overexpression Alters Aβ42 Levels and Behavior in Wildtype Mice., Hébert SS, Planel E, Loiselle A, Keraudren R, Petry S, Goupil C, Boscher E, Frontiers in neuroscience, 2020, 10.3389/fnins.2020.591138

Contribution à l'enseignement aux cycles supérieurs

Étudiant(e)s dirigé(e)s*

Depuis 2020/06
  • Aymane Lachhab - Maîtrise avec mémoire - En cours
  • Emma Rocaboy - Maîtrise avec mémoire - En cours
  • Kelly Godbout - Doctorat - En cours
  • Geoffrey Canet - Post-doctorat - En cours
  • Julius Baya Mdzomba - Doctorat - 2021/01
  • Parissa Fereydouni-Forouzandeh - Maîtrise avec mémoire - 2023/09
  • Sofía Diego Díaz - Maîtrise avec mémoire - 2025/01

Encadrement d'étudiant(e)s

Direction de recherche dans les domaines suivants :

  • Biologie cellulaire et moléculaire
  • Médecine moléculaire
  • Neurobiologie — Neurosciences
  • Sciences cliniques et biomédicales

En savoir plus sur les programmes

Disponibilité d'encadrement d'étudiant(e)s

Ce (cette) professeur(e) est présentement à la recherche d'étudiant(e)s.

Envoyer un courriel
*Les supervisions d’étudiant(e)s de 1er cycle en stage de recherche et de résident(e)s aux études médicales postdoctorales seront répertoriées ultérieurement.

Vice-décanat à la recherche et à l'innovation

Pavillon Ferdinand-Vandry
Université Laval
1050, avenue de la Médecine, local 4623
Québec (Québec) G1V 0A6
Canada

Renseignements - Secrétariat
418 656-2690
secretariatvdri@fmed.ulaval.ca

Jacques Simard
Vice-doyen à la recherche et à l'innovation
vice-doyen.recherche-et-innovation@fmed.ulaval.ca